787 hedge funds and large institutions have $11B invested in GSK in 2018 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 260 increasing their positions, 294 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

0.01% less ownership

Funds ownership: 4.43%4.42% (-0.01%)

1% less capital invested

Capital invested by funds: $11.1B → $11B (-$60.7M)

12% less repeat investments, than reductions

Existing positions increased: 260 | Existing positions reduced: 294

Holders
787
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
15
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$123M
Puts
$87.4M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
101
$8.84M
102
$8.79M
103
$8.78M
104
$8.28M
105
$8.12M
106
$8.05M
107
$7.91M
108
$7.77M
109
$7.68M
110
$7.32M
111
$7.21M
112
$6.9M
113
$6.77M
114
$6.7M
115
$6.58M
116
$6.54M
117
$6.48M
118
$6.32M
119
$6.23M
120
$6.13M
121
$6.08M
122
$6.06M
123
$6.03M
124
$6M
125
$5.92M